Epidemiology of recurrent respiratory papillomatosis

  title={Epidemiology of recurrent respiratory papillomatosis},
  author={Daniel A. Larson and Craig S Derkay},
Larson DA, Derkay CS. Epidemiology of recurrent respiratory papillomatosis. APMIS 2010; 118: 450–454. 
MVA E2 therapeutic vaccine for marked reduction in likelihood of recurrence of respiratory papillomatosis
Recurrent respiratory papillomatosis (RRP) or laryngeal papillomatosis is a disease caused by papillomavirus infection.
Recurrent Respiratory Papillomatosis: A Report of two cases and review of literature
Background: Recurrent Respiratory Papillomatosis (RRP) is a non-cancerous tumour of the upper airway caused by the human papilloma virus, present- ing as "wart-like" growth, which could be anywhere
Risk factors for adult‐onset recurrent respiratory papillomatosis
To evaluate risk factors strongly associated with adult‐onset recurrent respiratory papillomatosis (AO‐RRP), the objective was to establish an epidemiological literature review and assess the association between smoking and AO-RRP.
Prevalence and management of recurrent respiratory papillomatosis (RRP) in the UK: cross‐sectional study
To estimate the number of patients with recurrent respiratory papillomatosis currently managed in secondary and tertiary health care in the UK and the frequency of its treatment with radiofrequency
Current and future management of recurrent respiratory papillomatosis
This review provides perspectives on current and future management of RRP, a chronic disease of the respiratory tract that occurs in both children and adults.
Concurrent oral human papilloma virus infection in patients with recurrent respiratory papillomatosis: A preliminary study
To determine oral human papilloma virus (HPV) colonization in patients with adult‐onset recurrent respiratory papillomatosis (AO‐RRP) and their long‐term partners, data are analyzed through positron emission tomography and radiolysis for HPV colonization.
Juvenile recurrent respiratory papillomatosis: 10‐year audit and Australian prevalence estimates
To estimate the prevalence of juvenile onset recurrent respiratory papillomatosis in Australia, describe its epidemiological profile, and assess the positive predictive value of International Classification of Disease, 10th revision (ICD‐10) code D14.1 in children for hospitalization due to RRP, is estimated.
Juvenile recurrent respiratory papilloma: Variable intersurgical intervals
Analysis of patterns of surgical frequency in pediatric patients undergoing surgery with CO2 laser ablation for juvenile onset recurrent respiratory papillomatosis finds that over time there is a high variability in surgical frequency independent of the use of an adjuvant therapy.
A rare presentation of recurrent respiratory papillomatosis
A very rare presentation of RRP with diffuse tracheobronchial involvement is reported, which is usually a focal entity which predominantly involves the larynx.
Cost of treating recurrent respiratory papillomavirus in commercially insured and medicaid patients
The study objective was to estimate the first 2 years’ direct costs of treating new cases of juvenile‐onset and adult‐onset recurrent respiratory papillomatosis (RRP) and determine the predictors of


Risk factors for juvenile onset recurrent respiratory papillomatosis
Children born to condylomatous mothers are at risk for developing juvenile onset recurrent respiratory papillomatosis (JORRP) and the triad of vaginal delivery, being firstborn and maternal age of <20 years is inquired.
The epidemiology of juvenile onset recurrent respiratory papillomatosis derived from a population level national database
To develop a national database of cases of juvenile onset recurrent respiratory papillomatosis (JoRRP) in Canada, to calculate trends in incidence and prevalence of JoRRP from January 1994 to
Severity of juvenile onset recurrent respiratory papillomatosis is not associated with socioeconomic status in a setting of universal health care.
Role of cesarean section in prevention of recurrent respiratory papillomatosis--is there one?
  • J. Kosko, C. Derkay
  • Medicine
    International journal of pediatric otorhinolaryngology
  • 1996
The relationship between juvenile laryngeal papillomatosis and maternal condylomata acuminata.
This study attempted to delineate the relationship between juvenile laryngeal papillomatosis (JLP) in children and a history of maternal condyloma at the time of their birth by identifying 44 children with the clinical diagnosis of JLP over a period of 53 years.
Recurrent respiratory papillomatosis: an overview of current thinking and treatment
The low incidence of RRP does pose significant problems in recruitment of sufficient numbers to show statistical significance, so large multi-centre collaborative clinical trials are therefore required, and sufficient clinical follow-up data would take several years.
Initial results from the national registry for juvenile-onset recurrent respiratory papillomatosis. RRP Task Force.
Children whose disease was diagnosed before age 3 years were more likely than children aged 3 years or older to have more severe disease as measured by the mean number of surgical procedures performed and by the number of anatomical sites affected.
Recurring laryngeal papilloma
Laryngeal papillomavirus infection during clinical remission.
Biopsy samples from 20 patients with a history of laryngeal papillomas were analyzed by Southern blot hybridization for the presence of human papillomavirus DNA, and results explain the clinical pattern of frequent recurrences even after long-term remission in laryngesis.
Age of Child, More than HPV Type, Is Associated with Clinical Course in Recurrent Respiratory Papillomatosis
Patients with juvenile-onset RRP with at least 1 year of clinical data and infected with a single HPV type were analyzed and HPV 11 is more closely associated with a younger age at diagnosis than it is associated with an aggressive clinical course.